CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-16 | PARMAR KUSH Director | Sale | −91,836 | $15.30 | $1.4M | 1,766,634 |
| 2021-08-17 | Chakraborty Tirtha Chief Scientific Officer | Option exercise | +17,446 | $1.36 | $24K | 20,980 |
| 2021-08-17 | Chakraborty Tirtha Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −17,446 | 28,800 | ||
| 2021-04-01 | RA CAPITAL MANAGEMENT, L.P. Director | Other acquisition | +755,726 | $43.10 | $32.6M | 755,726 |
| 2021-04-01 | RA CAPITAL MANAGEMENT, L.P. Director | Other acquisition | +242,656 | $43.10 | $10.5M | 8,539,921 |
| 2021-02-09 | Alexandria Venture Investments, LLC 10% owner | Conversion | +282,804 | 282,804 | ||
| 2021-02-09 | Alexandria Venture Investments, LLC 10% owner | Conversion · Series B convertible preferred stock | −3,846,152 | 0 | ||
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Conversion | +3,308,822 | 3,308,822 | ||
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Conversion | +1,414,026 | 4,722,848 | ||
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Purchase | +111,111 | $18.00 | $2.0M | 4,833,959 |
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Conversion | +1,414,026 | 1,414,026 | ||
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Purchase | +444,444 | $18.00 | $8.0M | 1,858,470 |
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Conversion · Series A-2 Preferred Stock | −45,000,000 | 0 | ||
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Conversion · Series B Preferred Stock | −19,230,768 | 0 | ||
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Conversion · Series B Preferred Stock | −19,230,768 | 0 | ||
| 2021-02-09 | Jorgensen Nathan D. Chief Financial Officer | Conversion | +3,534 | 29,269 | ||
| 2021-02-09 | Jorgensen Nathan D. Chief Financial Officer | Conversion · Series B Preferred Stock | −48,076 | 0 | ||
| 2021-02-09 | Chakraborty Tirtha Chief Scientific Officer | Conversion | +3,534 | 3,534 | ||
| 2021-02-09 | Chakraborty Tirtha Chief Scientific Officer | Conversion · Series B Preferred Stock | −48,076 | 0 | ||
| 2021-02-09 | PARMAR KUSH Director | Conversion | +3,308,822 | 3,308,822 |
Page 16 of 18 · 344 trades